These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 27868150)
41. Optimal maintenance treatment with calcipotriol/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris: a multicentre randomized, controlled clinical trial. Lee JH; Park CJ; Kim TY; Choe YB; Kim NI; Song HJ; Youn JI; Youn SW; Choi JH; Kim KJ J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):483-489. PubMed ID: 27723134 [TBL] [Abstract][Full Text] [Related]
42. The distinct role and regulatory mechanism of IL-17 and IFN-γ in the initiation and development of plaque vs guttate psoriasis. Yan K; Han L; Deng H; Fang X; Zhang Z; Huang G; Zheng ZZ; Huang Q; Xu J J Dermatol Sci; 2018 Oct; 92(1):106-113. PubMed ID: 30072243 [TBL] [Abstract][Full Text] [Related]
43. [The calcipotriol-betamethasone dipropionate association]. Henry F; Flagothier C; Delvoye P; Piérard-Franchimont C; Piérard GE Rev Med Liege; 2005 Nov; 60(11):893-5. PubMed ID: 16402537 [TBL] [Abstract][Full Text] [Related]
44. Impact of topical emollient, steroids alone or combined with calcipotriol, on the immune infiltrate and clinical outcome in psoriasis. Heim M; Irondelle M; Duteil L; Cardot-Leccia N; Rocchi S; Passeron T; Tulic MK Exp Dermatol; 2022 Nov; 31(11):1764-1778. PubMed ID: 36054319 [TBL] [Abstract][Full Text] [Related]
45. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function. Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975 [TBL] [Abstract][Full Text] [Related]
46. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses. Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437 [TBL] [Abstract][Full Text] [Related]
47. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp. McCormack PL Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117 [TBL] [Abstract][Full Text] [Related]
48. Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study. van der Velden HM; Pasch MC; van Erp PE; van Lingen RG; Otero ME; de Boer-van Huizen RT; van de Kerkhof PC J Dermatolog Treat; 2010 Jan; 21(1):13-22. PubMed ID: 20055694 [TBL] [Abstract][Full Text] [Related]
49. Zinc finger protein A20 is involved in the antipsoriatic effect of calcipotriol. Liu X; Liu Y; Xu M; Li J; Teng X; Cheng H; Xia Y Br J Dermatol; 2016 Aug; 175(2):314-24. PubMed ID: 26875609 [TBL] [Abstract][Full Text] [Related]
50. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells. Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373 [TBL] [Abstract][Full Text] [Related]
51. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study. Glade CP; Van Erp PE; Van De Kerkhof PC Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429 [TBL] [Abstract][Full Text] [Related]
52. Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion. Fujiyama T; Ito T; Umayahara T; Ikeya S; Tatsuno K; Funakoshi A; Hashizume H; Tokura Y J Allergy Clin Immunol; 2016 Aug; 138(2):517-528.e5. PubMed ID: 27315769 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study. Reich K; Zschocke I; Bachelez H; de Jong EM; Gisondi P; Puig L; Warren RB; Mrowietz U; J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1156-63. PubMed ID: 25346093 [TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland. Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804 [TBL] [Abstract][Full Text] [Related]
55. Clearing of psoriasis documented by laser Doppler perfusion imaging contrasts remaining elevation of dermal expression levels of CD31. Hendriks AG; van de Kerkhof PC; de Jonge CS; Lucas M; Steenbergen W; Seyger MM Skin Res Technol; 2015 Aug; 21(3):340-5. PubMed ID: 25534374 [TBL] [Abstract][Full Text] [Related]
56. Once daily application of a combination of calcipotriol and betamethasone dipropionate (Dovobet, Daivobet) for the treatment of psoriasis. Lui H; Shapiro J Skin Therapy Lett; 2003; 8(Suppl 1):1-2. PubMed ID: 14961173 [TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial. Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259 [TBL] [Abstract][Full Text] [Related]
58. Iatrogenic adrenal insufficiency associated with calcipotriol-betamethasone topical combination in psoriasis. Giannitelli M; Maza A; Lahfa M; Meyer N; Livideanu C; Paul C Clin Exp Dermatol; 2010 Jun; 35(4):e167-8. PubMed ID: 20089083 [No Abstract] [Full Text] [Related]
60. Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris. Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Williams Z; Peyri Rey J; Svensson A; Toole J; Wozel G Dermatology; 2006; 213(4):319-26. PubMed ID: 17135738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]